The pharmacokinetics and pharmacodynamics of trental in pregnant women with chronic placental insufficiency

Zherdev, V.P.; Boĭko, S.S.; Vikhliaeva, E.M.; Supriaga, O.M.

Eksperimental'naia i Klinicheskaia Farmakologiia 56(2): 51-53

1993


ISSN/ISBN: 0869-2092
PMID: 8348041
Document Number: 418882
Examining the relationship between the pharmacokinetic characteristics of trental, its effect on platelet aggregation and adverse effects in pregnant females with chronic placental failure has allowed the optimal dosage regimen to be recommended in the third trimester in this abnormality. Its daily dose was found to be 400 mg (100 mg x 4).

Document emailed within 1 workday
Secure & encrypted payments